ARID1A and neoplasm: ARID1A low expression is also shown to increase the number of myeloid-derived suppressor cells (MDSCs) via an increased activation of the NF-κB signaling pathway to produce more CXCL2 and CXCL3 chemokines to recruit MDSCs to the tumor microenvironment.